Healthcare Sector Stocks
The Healthcare sector has a total of 1047 stocks, with a combined market cap of $9.17 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 48.50.
Market Cap
9.17T
Revenue
4.67T
Profits
189.14B
PE Ratio
48.50
Profit Margin
4.05%
Dividend Yield
0.39%
1048 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.02T | 2.70% | 1,041,660 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 644.96B | 0.77% | 1,383,063 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 462.67B | 1.83% | 1,624,757 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 358.50B | 0.96% | 3,201,537 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 345.16B | 1.44% | 1,727,622 | 450.53B |
| 6 | NVS | Novartis AG | 264.80B | 2.00% | 1,507,705 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 245.58B | 2.44% | 1,822,712 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 226.74B | 0.56% | 457,763 | 46.34B |
| 9 | AMGN | Amgen Inc. | 205.49B | 0.73% | 901,213 | 38.10B |
| 10 | NVO | Novo Nordisk A/S | 189.82B | 1.42% | 3,746,201 | 50.34B |
| 11 | GILD | Gilead Sciences, Inc. | 180.95B | 1.54% | 1,453,258 | 30.46B |
| 12 | ABT | Abbott Laboratories | 178.25B | 1.04% | 2,599,510 | 46.59B |
| 13 | PFE | Pfizer Inc. | 158.28B | 0.18% | 12,609,782 | 63.70B |
| 14 | DHR | Danaher Corporation | 142.83B | 1.52% | 1,019,037 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 132.98B | 1.97% | 997,143 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 131.42B | 0.60% | 239,629 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 131.18B | 0.91% | 2,335,983 | 49.19B |
| 18 | CVS | CVS Health Corporation | 122.22B | 0.96% | 1,562,405 | 412.65B |
| 19 | MDT | Medtronic plc | 119.36B | 2.58% | 3,965,951 | 37.54B |
| 20 | SYK | Stryker Corporation | 108.35B | 2.51% | 1,697,431 | 25.84B |
| 21 | MCK | McKesson Corporation | 104.52B | 1.70% | 211,589 | 410.98B |
| 22 | SNY | Sanofi | 101.87B | 1.74% | 1,471,812 | 55.89B |
| 23 | GSK | GSK plc | 95.94B | 4.28% | 1,784,681 | 44.05B |
| 24 | ELV | Elevance Health, Inc. | 91.88B | 1.18% | 375,599 | 201.11B |
| 25 | HCA | HCA Healthcare, Inc. | 91.40B | -1.12% | 422,835 | 78.01B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 79.49B | 1.87% | 186,142 | 15.53B |
| 27 | CI | The Cigna Group | 76.22B | 2.74% | 422,092 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 64.77B | 3.98% | 8,347,940 | 21.00B |
| 29 | ARGX | argenx SE | 61.97B | 1.69% | 82,067 | 5.32B |
| 30 | COR | Cencora, Inc. | 61.83B | 0.76% | 319,189 | 332.77B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 59.65B | 2.27% | 1,354,462 | 28.42B |
| 32 | MRNA | Moderna, Inc. | 58.68B | 2.10% | 5,388,800 | 2.23B |
| 33 | CAH | Cardinal Health, Inc. | 54.13B | -0.77% | 448,775 | 254.25B |
| 34 | HUM | Humana Inc. | 49.73B | 1.06% | 214,876 | 145.68B |
| 35 | BDX | Becton, Dickinson and Company | 49.32B | 1.81% | 471,079 | 22.48B |
| 36 | EW | Edwards Lifesciences Corporation | 49.21B | 1.19% | 1,020,514 | 6.51B |
| 37 | NTRA | Natera, Inc. | 48.36B | 1.99% | 425,157 | 2.71B |
| 38 | TEVA | Teva Pharmaceutical Industries Limited | 45.64B | 5.61% | 1,161,463 | 17.32B |
| 39 | IQV | IQVIA Holdings Inc. | 43.80B | 1.65% | 552,468 | 16.98B |
| 40 | RVMD | Revolution Medicines, Inc. | 43.75B | 0.17% | 575,196 | - |
| 41 | VEEV | Veeva Systems Inc. | 42.83B | 0.80% | 533,547 | 3.46B |
| 42 | MDLN | Medline Inc. | 42.81B | 0.09% | 1,614,692 | 29.94B |
| 43 | A | Agilent Technologies, Inc. | 41.17B | -0.62% | 555,888 | 7.37B |
| 44 | ONC | BeOne Medicines AG | 40.46B | 2.69% | 96,975 | 6.13B |
| 45 | IDXX | IDEXX Laboratories, Inc. | 40.13B | 0.92% | 164,622 | 4.55B |
| 46 | WAT | Waters Corporation | 40.06B | -0.14% | 215,465 | 4.64B |
| 47 | HLN | Haleon plc | 39.76B | 2.29% | 7,411,953 | 14.80B |
| 48 | CNC | Centene Corporation | 34.12B | 3.97% | 1,354,097 | 180.30B |
| 49 | RPRX | Royalty Pharma plc | 34.11B | 1.23% | 859,248 | 2.54B |
| 50 | ALNY | Alnylam Pharmaceuticals, Inc. | 33.47B | 0.58% | 320,776 | 4.80B |
| 51 | BIIB | Biogen Inc. | 32.41B | 1.01% | 196,394 | 10.03B |
| 52 | ALC | Alcon Inc. | 31.98B | 2.54% | 772,719 | 10.86B |
| 53 | RMD | ResMed Inc. | 31.97B | 2.37% | 262,627 | 5.65B |
| 54 | DXCM | DexCom, Inc. | 31.89B | 1.78% | 779,979 | 4.97B |
| 55 | ILMN | Illumina, Inc. | 31.37B | 0.63% | 682,279 | 4.49B |
| 56 | ZTS | Zoetis Inc. | 30.71B | 1.84% | 1,440,256 | 9.53B |
| 57 | ROIV | Roivant Sciences Ltd. | 29.88B | 1.35% | 1,586,244 | 7.53M |
| 58 | GEHC | GE HealthCare Technologies Inc. | 29.09B | 0.75% | 995,712 | 21.27B |
| 59 | INSM | Insmed Incorporated | 27.34B | -3.25% | 723,934 | 1.14B |
| 60 | DGX | Quest Diagnostics Incorporated | 26.04B | 0.38% | 343,937 | 11.56B |
| 61 | MTD | Mettler-Toledo International Inc. | 25.76B | -0.61% | 37,173 | 4.13B |
| 62 | LH | Labcorp Holdings Inc. | 25.18B | -0.32% | 239,518 | 14.35B |
| 63 | BNTX | BioNTech SE | 25.17B | 3.60% | 802,634 | 3.03B |
| 64 | INCY | Incyte Corporation | 24.98B | 1.46% | 460,432 | 5.82B |
| 65 | WST | West Pharmaceutical Services, Inc. | 24.81B | 1.81% | 168,083 | 3.33B |
| 66 | PHG | Koninklijke Philips N.V. | 23.98B | 2.28% | 402,864 | 20.18B |
| 67 | GH | Guardant Health, Inc. | 21.82B | 3.30% | 560,296 | 1.18B |
| 68 | UTHR | United Therapeutics Corporation | 21.65B | 1.55% | 149,884 | 3.15B |
| 69 | THC | Tenet Healthcare Corporation | 21.25B | 0.08% | 205,782 | 21.81B |
| 70 | STE | STERIS plc | 20.66B | 0.53% | 184,462 | 6.04B |
| 71 | GMAB | Genmab A/S | 19.41B | 1.11% | 763,552 | 4.13B |
| 72 | VTRS | Viatris Inc. | 19.27B | 1.64% | 2,726,718 | 14.74B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 18.35B | 2.92% | 707,484 | 8.51B |
| 74 | ASND | Ascendis Pharma A/S | 17.22B | -0.49% | 118,733 | 1.20B |
| 75 | MEDP | Medpace Holdings, Inc. | 16.57B | 1.03% | 81,923 | 2.78B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 16.04B | 0.53% | 154,600 | 4.60B |
| 77 | NBIX | Neurocrine Biosciences, Inc. | 16.02B | 0.89% | 314,351 | 3.37B |
| 78 | SOLV | Solventum Corporation | 15.16B | 1.86% | 215,497 | 8.31B |
| 79 | SMMT | Summit Therapeutics Inc. | 14.91B | 6.50% | 3,777,521 | - |
| 80 | BBIO | BridgeBio Pharma, Inc. | 14.27B | 0.80% | 545,261 | 713.07M |
| 81 | RVTY | Revvity, Inc. | 14.00B | 0.95% | 600,025 | 2.91B |
| 82 | EXEL | Exelixis, Inc. | 13.99B | 0.59% | 566,051 | 2.44B |
| 83 | ICLR | ICON Public Limited Company | 13.32B | 1.97% | 658,783 | 8.29B |
| 84 | CRL | Charles River Laboratories International, Inc. | 13.10B | -1.39% | 391,554 | 4.00B |
| 85 | BMRN | BioMarin Pharmaceutical Inc. | 12.92B | 1.60% | 454,108 | 3.41B |
| 86 | BTSG | BrightSpring Health Services, Inc. | 12.63B | 3.22% | 858,052 | 14.37B |
| 87 | PEN | Penumbra, Inc. | 12.59B | 0.61% | 45,140 | 1.50B |
| 88 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.46B | 0.86% | 68,770 | 1.28B |
| 89 | BAX | Baxter International Inc. | 12.34B | 0.25% | 1,280,183 | 11.47B |
| 90 | HALO | Halozyme Therapeutics, Inc. | 12.31B | 1.20% | 282,194 | 1.66B |
| 91 | CORT | Corcept Therapeutics Incorporated | 12.25B | 0.46% | 216,069 | 830.81M |
| 92 | EHC | Encompass Health Corporation | 12.16B | 1.30% | 206,612 | 6.21B |
| 93 | DVA | DaVita Inc. | 12.06B | 4.15% | 256,423 | 14.01B |
| 94 | FMS | Fresenius Medical Care AG | 11.82B | 2.24% | 389,317 | 22.19B |
| 95 | ELAN | Elanco Animal Health Incorporated | 11.72B | 1.21% | 987,584 | 5.02B |
| 96 | AXSM | Axsome Therapeutics, Inc. | 11.64B | 0.63% | 130,363 | 776.57M |
| 97 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.47B | -1.97% | 364,999 | 669.50M |
| 98 | SNN | Smith & Nephew plc | 11.47B | 3.27% | 815,910 | 6.30B |
| 99 | TECH | Bio-Techne Corporation | 11.33B | 0.21% | 1,550,399 | 1.22B |
| 100 | MOH | Molina Healthcare, Inc. | 11.12B | 4.48% | 215,206 | 42.47B |
| 101 | TEM | Tempus AI, Inc. | 11.11B | 4.30% | 2,299,727 | 1.43B |
| 102 | ALGN | Align Technology, Inc. | 10.81B | 0.93% | 147,432 | 4.14B |
| 103 | OSCR | Oscar Health, Inc. | 10.43B | 3.27% | 1,836,622 | 15.32B |
| 104 | CYTK | Cytokinetics, Incorporated | 10.28B | 0.28% | 613,275 | 67.67M |
| 105 | ABVX | ABIVAX Société Anonyme | 10.25B | -3.20% | 490,204 | 5.67M |
| 106 | COO | The Cooper Companies, Inc. | 10.24B | -0.07% | 1,992,753 | 4.24B |
| 107 | KRYS | Krystal Biotech, Inc. | 10.20B | -0.68% | 83,182 | 440.48M |
| 108 | RDY | Dr. Reddy's Laboratories Limited | 10.12B | 0.08% | 763,497 | 3.50B |
| 109 | AVTR | Avantor, Inc. | 10.11B | 0.95% | 4,100,637 | 6.56B |
| 110 | UHS | Universal Health Services, Inc. | 10.11B | -1.88% | 203,816 | 18.11B |
| 111 | GMED | Globus Medical, Inc. | 10.09B | 1.25% | 513,090 | 3.14B |
| 112 | ENSG | The Ensign Group, Inc. | 10.05B | -0.02% | 78,607 | 5.49B |
| 113 | GKOS | Glaukos Corporation | 9.99B | 1.32% | 189,101 | 612.84M |
| 114 | KRSA | Korsana Biosciences, Inc. | 9.97B | -3.46% | 29,612 | - |
| 115 | BIO | Bio-Rad Laboratories, Inc. | 9.89B | 0.12% | 57,812 | 2.59B |
| 116 | HSIC | Henry Schein, Inc. | 9.82B | -0.28% | 281,500 | 13.60B |
| 117 | KYMR | Kymera Therapeutics, Inc. | 9.62B | 0.59% | 183,268 | 105.00M |
| 118 | PTGX | Protagonist Therapeutics, Inc. | 9.57B | -0.20% | 166,014 | 281.99M |
| 119 | PODD | Insulet Corporation | 9.49B | 3.69% | 1,238,414 | 3.05B |
| 120 | RGEN | Repligen Corporation | 9.42B | 1.06% | 179,981 | 785.10M |
| 121 | PRAX | Praxis Precision Medicines, Inc. | 9.29B | -0.54% | 166,470 | 7.46M |
| 122 | PCVX | Vaxcyte, Inc. | 9.00B | 1.65% | 674,977 | - |
| 123 | TXG | 10x Genomics, Inc. | 8.90B | -0.39% | 1,776,926 | 616.91M |
| 124 | IONS | Ionis Pharmaceuticals, Inc. | 8.84B | -1.86% | 1,618,197 | 874.09M |
| 125 | IBRX | ImmunityBio, Inc. | 8.82B | 5.18% | 4,261,618 | 165.79M |
| 126 | QGEN | Qiagen N.V. | 8.76B | -0.38% | 541,510 | 2.10B |
| 127 | TWST | Twist Bioscience Corporation | 8.45B | 5.91% | 934,023 | 431.80M |
| 128 | BRKR | Bruker Corporation | 8.01B | -1.65% | 1,073,406 | 3.50B |
| 129 | SYRE | Spyre Therapeutics, Inc. | 8.00B | 0.10% | 450,535 | - |
| 130 | ATR | AptarGroup, Inc. | 7.99B | 0.66% | 134,210 | 3.93B |
| 131 | HQY | HealthEquity, Inc. | 7.93B | -0.38% | 413,828 | 1.36B |
| 132 | IMVT | Immunovant, Inc. | 7.84B | 1.55% | 345,145 | - |
| 133 | ALKS | Alkermes plc | 7.72B | 0.13% | 503,121 | 1.67B |
| 134 | TGTX | TG Therapeutics, Inc. | 7.64B | -0.07% | 312,248 | 799.54M |
| 135 | HNGE | Hinge Health, Inc. | 7.54B | 5.51% | 723,266 | 720.06M |
| 136 | CAI | Caris Life Sciences, Inc. | 7.15B | 3.90% | 1,068,950 | 989.61M |
| 137 | BLTE | Belite Bio, Inc | 7.07B | 0.97% | 42,759 | - |
| 138 | PACS | PACS Group, Inc. | 7.05B | -0.47% | 191,958 | 5.55B |
| 139 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.99B | -3.00% | 271,525 | 239.92M |
| 140 | HIMS | Hims & Hers Health, Inc. | 6.84B | 6.54% | 6,416,150 | 2.58B |
| 141 | GRFS | Grifols, S.A. | 6.80B | -0.26% | 176,160 | 8.48B |
| 142 | CHE | Chemed Corporation | 6.69B | -0.34% | 50,681 | 2.60B |
| 143 | CGON | CG Oncology, Inc. | 6.57B | 2.46% | 194,755 | 6.23M |
| 144 | LNTH | Lantheus Holdings, Inc. | 6.54B | -0.03% | 354,892 | 1.56B |
| 145 | SRRK | Scholar Rock Holding Corporation | 6.48B | -4.04% | 1,943,007 | - |
| 146 | MIRM | Mirum Pharmaceuticals, Inc. | 6.43B | 0.90% | 176,328 | 618.07M |
| 147 | ORKA | Oruka Therapeutics, Inc. | 6.36B | 3.98% | 266,916 | - |
| 148 | TVTX | Travere Therapeutics, Inc. | 6.36B | 1.95% | 327,326 | 591.33M |
| 149 | BLCO | Bausch + Lomb Corporation | 6.21B | 0.75% | 64,139 | 5.32B |
| 150 | MMED | MiniMed Group, Inc. | 6.15B | -2.80% | 2,067,671 | 3.22B |
| 151 | DNTH | Dianthus Therapeutics, Inc. | 6.09B | 2.51% | 171,075 | 1.90M |
| 152 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.01B | 1.05% | 177,503 | 840.85M |
| 153 | AMRX | Amneal Pharmaceuticals, Inc. | 5.99B | 1.06% | 579,063 | 3.12B |
| 154 | RDNT | RadNet, Inc. | 5.98B | 0.65% | 247,934 | 2.27B |
| 155 | LQDA | Liquidia Corporation | 5.94B | -0.52% | 449,390 | 450.91M |
| 156 | COGT | Cogent Biosciences, Inc. | 5.79B | -0.12% | 518,065 | - |
| 157 | ERAS | Erasca, Inc. | 5.73B | 3.21% | 940,815 | - |
| 158 | STVN | Stevanato Group S.p.A. | 5.68B | -0.48% | 137,403 | 1.40B |
| 159 | LGND | Ligand Pharmaceuticals Incorporated | 5.67B | 0.04% | 39,381 | 290.54M |
| 160 | XENE | Xenon Pharmaceuticals Inc. | 5.67B | -0.12% | 139,124 | 7.50M |
| 161 | PTCT | PTC Therapeutics, Inc. | 5.56B | 0.91% | 390,536 | 1.01B |
| 162 | TFX | Teleflex Incorporated | 5.52B | -0.46% | 228,122 | 2.25B |
| 163 | DFTX | Definium Therapeutics, Inc. | 5.45B | 4.29% | 4,285,882 | - |
| 164 | SHC | Sotera Health Company | 5.30B | 1.06% | 455,447 | 1.22B |
| 165 | CRSP | CRISPR Therapeutics AG | 5.18B | 3.50% | 796,078 | 13.39M |
| 166 | MMSI | Merit Medical Systems, Inc. | 5.17B | 0.20% | 114,029 | 1.58B |
| 167 | LFST | LifeStance Health Group, Inc. | 5.14B | 3.70% | 1,554,108 | 1.58B |
| 168 | EWTX | Edgewise Therapeutics, Inc. | 4.94B | 2.49% | 456,448 | - |
| 169 | HAE | Haemonetics Corporation | 4.76B | 1.97% | 237,831 | 1.35B |
| 170 | ACAD | ACADIA Pharmaceuticals Inc. | 4.76B | -0.72% | 989,543 | 1.14B |
| 171 | BLLN | BillionToOne, Inc. | 4.75B | 1.90% | 161,392 | 397.41M |
| 172 | WAY | Waystar Holding Corp. | 4.75B | 5.50% | 525,846 | 1.21B |
| 173 | DOCS | Doximity, Inc. | 4.62B | 1.41% | 801,427 | 655.57M |
| 174 | CON | Concentra Group Holdings Parent, Inc. | 4.56B | 2.29% | 291,345 | 2.29B |
| 175 | PBLS | Parabilis Medicines, Inc. | 4.49B | -1.38% | 195,515 | 148.00K |
| 176 | LIVN | LivaNova PLC | 4.42B | 2.61% | 178,753 | 1.47B |
| 177 | HTFL | HeartFlow, Inc. | 4.33B | -0.20% | 639,099 | 212.07M |
| 178 | ITGR | Integer Holdings Corporation | 4.29B | 0.18% | 325,875 | 1.84B |
| 179 | MANE | Veradermics, Incorporated | 4.28B | 3.41% | 224,101 | - |
| 180 | RLAY | Relay Therapeutics, Inc. | 4.22B | 2.12% | 939,101 | 10.35M |
| 181 | IOVA | Iovance Biotherapeutics, Inc. | 4.20B | 7.79% | 6,423,761 | 324.97M |
| 182 | NVST | Envista Holdings Corporation | 4.15B | 1.02% | 923,771 | 2.86B |
| 183 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.13B | 3.98% | 496,801 | -665.00K |
| 184 | INDV | Indivior Pharmaceuticals, Inc. | 4.11B | 0.96% | 449,072 | 1.33B |
| 185 | TNGX | Tango Therapeutics, Inc. | 4.11B | 2.48% | 791,328 | 53.81M |
| 186 | CELC | Celcuity Inc. | 4.08B | -0.12% | 809,935 | - |
| 187 | ELVN | Enliven Therapeutics, Inc. | 4.05B | 1.75% | 307,621 | - |
| 188 | TLX | Telix Pharmaceuticals Limited | 3.98B | 5.14% | 486,462 | 890.79M |
| 189 | PLSE | Pulse Biosciences, Inc. | 3.96B | 4.56% | 203,567 | 1.19M |
| 190 | ADPT | Adaptive Biotechnologies Corporation | 3.95B | 2.23% | 338,672 | 308.08M |
| 191 | ICUI | ICU Medical, Inc. | 3.94B | 0.68% | 61,715 | 2.16B |
| 192 | IRTC | iRhythm Holdings, Inc. | 3.79B | 3.27% | 194,265 | 825.34M |
| 193 | VKTX | Viking Therapeutics, Inc. | 3.71B | -0.56% | 763,280 | - |
| 194 | IDYA | IDEAYA Biosciences, Inc. | 3.69B | 1.62% | 171,278 | 234.13M |
| 195 | LEGN | Legend Biotech Corporation | 3.64B | 0.86% | 935,949 | 1.27B |
| 196 | ABCL | AbCellera Biologics Inc. | 3.63B | 2.89% | 2,483,729 | 66.17M |
| 197 | OGN | Organon & Co. | 3.58B | 0.04% | 452,890 | 6.13B |
| 198 | OPCH | Option Care Health, Inc. | 3.56B | 1.19% | 350,887 | 5.69B |
| 199 | NHC | National HealthCare Corporation | 3.54B | 0.70% | 28,013 | 1.56B |
| 200 | DYN | Dyne Therapeutics, Inc. | 3.51B | 3.08% | 1,015,900 | - |
| 201 | TARS | Tarsus Pharmaceuticals, Inc. | 3.47B | -0.38% | 201,674 | 606.33M |
| 202 | DNLI | Denali Therapeutics Inc. | 3.43B | 1.71% | 380,719 | 3.60M |
| 203 | GRAL | GRAIL, Inc. | 3.39B | -0.51% | 520,530 | 165.26M |
| 204 | VCYT | Veracyte, Inc. | 3.31B | 0.88% | 353,453 | 561.90M |
| 205 | AVAH | Aveanna Healthcare Holdings Inc. | 3.19B | 3.84% | 1,015,116 | 2.60B |
| 206 | QURE | uniQure N.V. | 3.16B | 2.34% | 247,512 | 18.67M |
| 207 | WRBY | Warby Parker Inc. | 3.15B | 2.99% | 1,208,737 | 911.61M |
| 208 | RCUS | Arcus Biosciences, Inc. | 3.12B | -0.49% | 761,365 | 117.00M |
| 209 | ARQT | Arcutis Biotherapeutics, Inc. | 3.06B | 1.93% | 541,366 | 463.98M |
| 210 | CLDX | Celldex Therapeutics, Inc. | 3.04B | 4.99% | 211,410 | 158.00K |
| 211 | TMDX | TransMedics Group, Inc. | 2.95B | 3.67% | 338,278 | 668.47M |
| 212 | GRDN | Guardian Pharmacy Services, Inc. | 2.94B | 6.19% | 337,450 | 1.46B |
| 213 | BKD | Brookdale Senior Living Inc. | 2.90B | -0.08% | 705,579 | 2.93B |
| 214 | MBX | MBX Biosciences, Inc. | 2.87B | 0.91% | 108,520 | - |
| 215 | IMNM | Immunome, Inc. | 2.85B | 1.86% | 232,975 | 4.02M |
| 216 | ATRC | AtriCure, Inc. | 2.84B | 2.22% | 395,337 | 569.62M |
| 217 | RGC | Regencell Bioscience Holdings Limited | 2.83B | 1.32% | 46,481 | - |
| 218 | PHVS | Pharvaris N.V. | 2.77B | 3.81% | 477,900 | - |
| 219 | GPCR | Structure Therapeutics Inc. | 2.75B | -0.08% | 235,014 | - |
| 220 | ZLAB | Zai Lab Limited | 2.73B | 0.75% | 533,585 | 449.61M |
| 221 | NAMS | NewAmsterdam Pharma Company N.V. | 2.72B | -0.22% | 524,422 | 7.12M |
| 222 | CLOV | Clover Health Investments, Corp. | 2.70B | 5.39% | 2,480,345 | 2.48B |
| 223 | ALHC | Alignment Healthcare, Inc. | 2.69B | 2.78% | 914,069 | 4.58B |
| 224 | CDNA | CareDx, Inc. | 2.69B | 3.36% | 241,972 | 458.09M |
| 225 | PRVA | Privia Health Group, Inc. | 2.68B | 2.94% | 487,514 | 2.36B |
| 226 | NRIX | Nurix Therapeutics, Inc. | 2.68B | 3.07% | 408,127 | 36.77M |
| 227 | IRON | Disc Medicine, Inc. | 2.66B | -0.94% | 272,753 | - |
| 228 | ACHC | Acadia Healthcare Company, Inc. | 2.64B | 0.18% | 267,921 | 3.37B |
| 229 | WGS | GeneDx Holdings Corp. | 2.64B | 3.91% | 148,947 | 454.43M |
| 230 | NEOG | Neogen Corporation | 2.58B | 0.59% | 462,599 | 870.40M |
| 231 | AXGN | Axogen, Inc. | 2.57B | 4.03% | 706,421 | 251.17M |
| 232 | MLYS | Mineralys Therapeutics, Inc. | 2.54B | 1.88% | 323,961 | - |
| 233 | PGEN | Precigen, Inc. | 2.52B | 2.77% | 1,728,699 | 85.72M |
| 234 | VRDN | Viridian Therapeutics, Inc. | 2.51B | 4.19% | 503,633 | 71.13M |
| 235 | BEAM | Beam Therapeutics Inc. | 2.48B | 3.63% | 650,234 | 156.04M |
| 236 | SLS | SELLAS Life Sciences Group, Inc. | 2.47B | 5.93% | 7,209,211 | - |
| 237 | SUPN | Supernus Pharmaceuticals, Inc. | 2.47B | 1.92% | 321,007 | 830.44M |
| 238 | VERA | Vera Therapeutics, Inc. | 2.46B | -2.43% | 902,858 | - |
| 239 | HRMY | Harmony Biosciences Holdings, Inc. | 2.42B | 0.26% | 254,673 | 959.90M |
| 240 | NKTR | Nektar Therapeutics | 2.37B | -0.39% | 185,130 | 54.59M |
| 241 | OCUL | Ocular Therapeutix, Inc. | 2.37B | 2.67% | 489,817 | 52.06M |
| 242 | NEO | NeoGenomics, Inc. | 2.30B | 3.41% | 307,380 | 766.30M |
| 243 | TRLV | Trulieve Cannabis Corp. | 2.30B | 5.39% | 738,156 | 1.14B |
| 244 | TRVI | Trevi Therapeutics, Inc. | 2.28B | 0.57% | 436,145 | - |
| 245 | PBH | Prestige Consumer Healthcare Inc. | 2.28B | 2.32% | 137,656 | 1.10B |
| 246 | BHC | Bausch Health Companies Inc. | 2.26B | 3.24% | 4,212,411 | 10.85B |
| 247 | HCM | HUTCHMED (China) Limited | 2.26B | 6.71% | 69,803 | 549.12M |
| 248 | SRPT | Sarepta Therapeutics, Inc. | 2.21B | 2.40% | 904,292 | 1.97B |
| 249 | AUPH | Aurinia Pharmaceuticals Inc. | 2.20B | 2.48% | 267,415 | 311.51M |
| 250 | PVLA | Palvella Therapeutics, Inc. | 2.18B | 0.95% | 44,996 | - |
| 251 | UFPT | UFP Technologies, Inc. | 2.16B | 0.15% | 50,472 | 631.64M |
| 252 | INSP | Inspire Medical Systems, Inc. | 2.15B | 2.01% | 463,081 | 898.74M |
| 253 | ESTA | Establishment Labs Holdings Inc. | 2.14B | 0.99% | 68,640 | 245.82M |
| 254 | MD | Pediatrix Medical Group, Inc. | 2.13B | 0.37% | 189,964 | 1.95B |
| 255 | ADUS | Addus HomeCare Corporation | 2.13B | -0.54% | 64,863 | 1.48B |
| 256 | RAPP | Rapport Therapeutics, Inc. | 2.13B | 1.77% | 68,306 | 20.00M |
| 257 | PGNY | Progyny, Inc. | 2.13B | 1.35% | 251,949 | 1.31B |
| 258 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.13B | 2.46% | 1,714,268 | 940.61M |
| 259 | URGN | UroGen Pharma Ltd. | 2.12B | 2.43% | 194,798 | 188.73M |
| 260 | NUVB | Nuvation Bio Inc. | 2.12B | -0.66% | 2,290,936 | 169.90M |
| 261 | KOD | Kodiak Sciences Inc. | 2.10B | 1.89% | 178,489 | - |
| 262 | XRAY | DENTSPLY SIRONA Inc. | 2.10B | 0.76% | 837,476 | 3.64B |
| 263 | GENB | Generate Biomedicines, Inc. | 2.09B | 3.37% | 537,378 | 26.48M |
| 264 | ZBIO | Zenas BioPharma, Inc. | 2.07B | 2.19% | 109,574 | 1.00M |
| 265 | CMPS | COMPASS Pathways plc | 2.07B | 4.18% | 1,400,438 | - |
| 266 | ADMA | ADMA Biologics, Inc. | 2.05B | -0.87% | 863,974 | 512.28M |
| 267 | VCEL | Vericel Corporation | 2.02B | 3.13% | 185,043 | 306.30M |
| 268 | ASTH | Astrana Health, Inc. | 2.02B | 3.77% | 51,517 | 3.84B |
| 269 | AGIO | Agios Pharmaceuticals, Inc. | 1.99B | -0.68% | 182,521 | 98.34M |
| 270 | BFLY | Butterfly Network, Inc. | 1.99B | 1.77% | 1,227,537 | 112.14M |
| 271 | PRGO | Perrigo Company plc | 1.98B | 4.39% | 439,223 | 4.14B |
| 272 | MESO | Mesoblast Limited | 1.97B | -2.52% | 111,236 | 120.25M |
| 273 | ALMR | Alamar Biosciences, Inc. | 1.94B | - | 129,281 | 100.42M |
| 274 | BHVN | Biohaven Ltd. | 1.93B | 0.71% | 528,610 | - |
| 275 | GHRS | GH Research PLC | 1.93B | 3.47% | 61,296 | - |
| 276 | ZYME | Zymeworks Inc. | 1.91B | 2.52% | 221,518 | 37.13M |
| 277 | STOK | Stoke Therapeutics, Inc. | 1.91B | 1.76% | 143,858 | 27.59M |
| 278 | SNDA | Sonida Senior Living, Inc. | 1.88B | 0.56% | 90,333 | 481.07M |
| 279 | NVCR | NovoCure Limited | 1.87B | 3.74% | 192,151 | 699.19M |
| 280 | COAG | Hemab Therapeutics Holdings, Inc. | 1.86B | 1.29% | 217,340 | - |
| 281 | SEPN | Septerna, Inc. | 1.86B | 3.27% | 141,140 | 98.88M |
| 282 | VIR | Vir Biotechnology, Inc. | 1.85B | 2.73% | 621,276 | 303.23M |
| 283 | NBTX | Nanobiotix S.A. | 1.85B | -1.97% | 106,429 | 38.27M |
| 284 | LMAT | LeMaitre Vascular, Inc. | 1.84B | 0.06% | 61,191 | 262.43M |
| 285 | SGRY | Surgery Partners, Inc. | 1.84B | -1.18% | 433,587 | 3.37B |
| 286 | ALVO | Alvotech | 1.84B | -2.74% | 256,766 | 494.61M |
| 287 | XNCR | Xencor, Inc. | 1.83B | 1.09% | 317,103 | 104.97M |
| 288 | RXRX | Recursion Pharmaceuticals, Inc. | 1.82B | 6.25% | 7,410,474 | 54.86M |
| 289 | DMRA | Damora Therapeutics, Inc. | 1.79B | 3.31% | 119,576 | - |
| 290 | KLRA | Kailera Therapeutics, Inc. | 1.78B | -1.29% | 403,447 | - |
| 291 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.76B | 3.98% | 602,703 | 208.78M |
| 292 | LKFT | Lakefront Biotherapeutics NV | 1.76B | 0.52% | 171,427 | 1.13B |
| 293 | PSNL | Personalis, Inc. | 1.75B | 1.05% | 913,525 | 69.67M |
| 294 | BLFS | BioLife Solutions, Inc. | 1.73B | 1.26% | 194,397 | 106.69M |
| 295 | KARD | Kardigan, Inc. | 1.73B | -0.16% | 333,298 | - |
| 296 | BRVE | Braveheart Bio, Inc. | 1.73B | 0.92% | 90,911 | - |
| 297 | NTLA | Intellia Therapeutics, Inc. | 1.69B | 2.90% | 1,285,550 | 59.51M |
| 298 | IMCR | Immunocore Holdings plc | 1.69B | 0.58% | 97,717 | 430.78M |
| 299 | ETON | Eton Pharmaceuticals, Inc. | 1.68B | 2.70% | 117,120 | 105.60M |
| 300 | SNDX | Syndax Pharmaceuticals, Inc. | 1.67B | 2.64% | 325,810 | 252.25M |
| 301 | ATEC | Alphatec Holdings, Inc. | 1.66B | 1.89% | 1,786,443 | 815.05M |
| 302 | TSHA | Taysha Gene Therapies, Inc. | 1.65B | 1.10% | 878,097 | 5.49M |
| 303 | FTRE | Fortrea Holdings Inc. | 1.65B | 0.64% | 634,193 | 2.68B |
| 304 | ANAB | AnaptysBio, Inc. | 1.64B | 2.67% | 163,775 | 232.39M |
| 305 | AVLN | Avalyn Pharma Inc. | 1.60B | 7.24% | 280,218 | - |
| 306 | INBX | Inhibrx Biosciences, Inc. | 1.59B | -1.19% | 102,967 | 1.30M |
| 307 | NVAX | Novavax, Inc. | 1.58B | 1.59% | 1,736,394 | 413.80M |
| 308 | FRNM | Freenome, Inc. | 1.57B | 1.64% | 236,826 | 35.41M |
| 309 | LTGO | Latigo Biotherapeutics, Inc. | 1.56B | 6.41% | 63,323 | - |
| 310 | BCAX | Bicara Therapeutics Inc. | 1.56B | 3.46% | 158,451 | - |
| 311 | ARDT | Ardent Health, Inc. | 1.56B | 0.46% | 138,492 | 6.41B |
| 312 | ANIP | ANI Pharmaceuticals, Inc. | 1.54B | 2.27% | 86,800 | 978.38M |
| 313 | AGL | agilon health, inc. | 1.53B | 1.35% | 67,648 | 5.92B |
| 314 | INVA | Innoviva, Inc. | 1.52B | 1.89% | 174,334 | 440.00M |
| 315 | OMCL | Omnicell, Inc. | 1.51B | 1.19% | 88,749 | 1.25B |
| 316 | HCSG | Healthcare Services Group, Inc. | 1.51B | 0.23% | 132,859 | 1.86B |
| 317 | TYRA | Tyra Biosciences, Inc. | 1.51B | 14.75% | 1,018,090 | - |
| 318 | AAPG | Ascentage Pharma Group International | 1.50B | 1.96% | 1,713 | 94.61M |
| 319 | INNV | InnovAge Holding Corp. | 1.50B | 2.42% | 54,205 | 989.71M |
| 320 | NUTX | Nutex Health Inc. | 1.48B | 8.02% | 148,011 | 846.72M |
| 321 | PAHC | Phibro Animal Health Corporation | 1.47B | 1.57% | 90,531 | 1.52B |
| 322 | LBRX | LB Pharmaceuticals Inc | 1.46B | 1.50% | 66,399 | - |
| 323 | SDGR | Schrödinger, Inc. | 1.45B | 2.26% | 313,178 | 259.04M |
| 324 | AVBP | ArriVent BioPharma, Inc. | 1.43B | -0.31% | 82,471 | - |
| 325 | MAZE | Maze Therapeutics, Inc. | 1.41B | 3.46% | 319,391 | 20.00M |
| 326 | ABSI | Absci Corporation | 1.40B | -0.37% | 1,410,657 | 1.56M |
| 327 | XERS | Xeris Biopharma Holdings, Inc. | 1.40B | 2.82% | 391,880 | 335.41M |
| 328 | CNMD | CONMED Corporation | 1.39B | 0.32% | 76,526 | 1.37B |
| 329 | PNTG | The Pennant Group, Inc. | 1.39B | 1.53% | 63,593 | 1.10B |
| 330 | VOR | Vor Biopharma Inc. | 1.38B | 4.80% | 368,642 | - |
| 331 | AZTA | Azenta, Inc. | 1.38B | 2.04% | 200,788 | 613.81M |
| 332 | KMTS | Kestra Medical Technologies, Ltd. | 1.38B | 2.89% | 169,250 | 95.13M |
| 333 | TRAX | First Tracks Biotherapeutics, Inc. | 1.37B | 5.05% | 209,190 | - |
| 334 | RARE | Ultragenyx Pharmaceutical Inc. | 1.36B | -3.08% | 2,483,482 | 717.00M |
| 335 | SVRA | Savara Inc. | 1.36B | 1.13% | 405,042 | - |
| 336 | DRTS | Alpha Tau Medical Ltd. | 1.36B | 1.87% | 200,711 | - |
| 337 | CGEM | Cullinan Therapeutics, Inc. | 1.34B | 0.78% | 634,871 | - |
| 338 | OMER | Omeros Corporation | 1.32B | -0.38% | 623,582 | 38.42M |
| 339 | AMN | AMN Healthcare Services, Inc. | 1.31B | 1.71% | 159,691 | 3.43B |
| 340 | SPTX | Seaport Therapeutics, Inc. | 1.31B | 4.84% | 66,102 | - |
| 341 | AKTS | Aktis Oncology, Inc. | 1.31B | 1.03% | 105,011 | 10.06M |
| 342 | HROW | Harrow, Inc. | 1.29B | -0.12% | 255,765 | 275.59M |
| 343 | ORIC | ORIC Pharmaceuticals, Inc. | 1.29B | 3.16% | 404,306 | - |
| 344 | OMDA | Omada Health, Inc. | 1.29B | 6.87% | 379,571 | 309.76M |
| 345 | REPL | Replimune Group, Inc. | 1.26B | 3.64% | 907,794 | - |
| 346 | MGTX | MeiraGTx Holdings plc | 1.26B | 2.42% | 207,551 | 397.50M |
| 347 | ANRO | Alto Neuroscience, Inc. | 1.25B | -0.56% | 137,235 | - |
| 348 | AORT | Artivion, Inc. | 1.22B | -0.24% | 131,743 | 471.47M |
| 349 | IART | Integra LifeSciences Holdings Corporation | 1.21B | 0.65% | 192,037 | 1.65B |
| 350 | MNKD | MannKind Corporation | 1.21B | 0.53% | 1,410,482 | 393.63M |
| 351 | PRCT | PROCEPT BioRobotics Corporation | 1.21B | 3.48% | 677,155 | 337.34M |
| 352 | TNDM | Tandem Diabetes Care, Inc. | 1.20B | 0.58% | 516,904 | 1.04B |
| 353 | USPH | U.S. Physical Therapy, Inc. | 1.20B | 1.85% | 100,002 | 804.27M |
| 354 | GDRX | GoodRx Holdings, Inc. | 1.20B | 3.39% | 427,472 | 785.23M |
| 355 | SLBT | SL Science Holding Limited | 1.19B | 1.46% | 72,496 | 3.27M |
| 356 | IMTX | Immatics N.V. | 1.19B | -0.91% | 97,622 | 47.65M |
| 357 | CERT | Certara, Inc. | 1.19B | 3.05% | 419,000 | 421.75M |
| 358 | ODTX | Odyssey Therapeutics, Inc. | 1.19B | 0.51% | 78,320 | 99.00K |
| 359 | JBIO | Jade Biosciences, Inc. | 1.18B | 3.86% | 295,268 | - |
| 360 | ALMS | Alumis Inc. | 1.18B | -0.98% | 1,615,612 | 7.40M |
| 361 | TDOC | Teladoc Health, Inc. | 1.17B | 4.95% | 1,352,526 | 2.49B |
| 362 | OPK | OPKO Health, Inc. | 1.16B | -1.27% | 945,242 | 587.90M |
| 363 | GLUE | Monte Rosa Therapeutics, Inc. | 1.15B | -3.84% | 988,661 | 28.73M |
| 364 | CRON | Cronos Group Inc. | 1.15B | 2.71% | 534,006 | 179.09M |
| 365 | STAA | STAAR Surgical Company | 1.14B | 0.75% | 316,145 | 339.59M |
| 366 | ATTO | Attovia Therapeutics, Inc. | 1.12B | 7.59% | 191,086 | 1.80M |
| 367 | CRVS | Corvus Pharmaceuticals, Inc. | 1.11B | 2.48% | 422,448 | - |
| 368 | BVS | Bioventus Inc. | 1.11B | 1.85% | 113,433 | 581.85M |
| 369 | LMRI | Lumexa Imaging Holdings, Inc. | 1.11B | 0.17% | 72,015 | 1.04B |
| 370 | OBX | Obsidian Therapeutics, Inc. | 1.11B | 0.56% | 271,797 | - |
| 371 | MLTX | MoonLake Immunotherapeutics | 1.09B | 2.64% | 1,428,077 | - |
| 372 | APMD | Apnimed, Inc. | 1.08B | -1.45% | 110,456 | 115.12M |
| 373 | ENOV | Enovis Corporation | 1.07B | -4.07% | 855,447 | 2.30B |
| 374 | JANX | Janux Therapeutics, Inc. | 1.07B | 1.96% | 341,113 | 24.00M |
| 375 | IRMD | IRADIMED CORPORATION | 1.06B | 0.80% | 26,689 | 86.34M |
| 376 | KURA | Kura Oncology, Inc. | 1.04B | 2.24% | 475,463 | 77.23M |
| 377 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.03B | 1.98% | 168,847 | 730.02M |
| 378 | GMRS | GMR Solutions Inc. | 1.02B | 2.93% | 244,264 | 5.88B |
| 379 | FTH | Faeth Therapeutics, Inc. | 1.02B | 5.66% | 122,928 | - |
| 380 | ANL | Adlai Nortye Group Ltd. | 1.02B | 4.36% | 88,055 | 18.06M |
| 381 | ABUS | Arbutus Biopharma Corporation | 1.02B | 0.39% | 1,470,668 | 181.72M |
| 382 | PCRX | Pacira BioSciences, Inc. | 1.00B | -0.59% | 142,427 | 746.16M |
| 383 | CSTL | Castle Biosciences, Inc. | 999.58M | 1.21% | 44,244 | 357.28M |
| 384 | HELP | Cybin Inc. | 990.70M | 4.55% | 827,276 | - |
| 385 | SANA | Sana Biotechnology, Inc. | 966.93M | 3.19% | 1,046,229 | - |
| 386 | SLDB | Solid Biosciences Inc. | 953.23M | 2.18% | 351,196 | - |
| 387 | SGP | SpyGlass Pharma, Inc. | 940.56M | 2.18% | 47,589 | - |
| 388 | CBLL | CeriBell, Inc. | 934.12M | 3.00% | 96,830 | 101.96M |
| 389 | IVA | Inventiva S.A. | 928.49M | -1.24% | 941,182 | 7.94M |
| 390 | WVE | Wave Life Sciences, Inc. | 896.57M | -0.87% | 807,298 | 65.37M |
| 391 | IMMX | Immix Biopharma, Inc. | 894.96M | 3.05% | 401,050 | - |
| 392 | LXRX | Lexicon Pharmaceuticals, Inc. | 894.36M | 0.50% | 840,802 | 41.47M |
| 393 | ARDX | Ardelyx, Inc. | 888.35M | -0.42% | 1,597,717 | 450.89M |
| 394 | OLMA | Olema Pharmaceuticals, Inc. | 885.48M | -0.98% | 1,000,457 | - |
| 395 | TBPH | Theravance Biopharma, Inc. | 883.66M | 0.06% | 77,081 | 104.31M |
| 396 | GERN | Geron Corporation | 883.40M | 1.85% | 3,648,514 | 204.56M |
| 397 | AVTX | Avalo Therapeutics, Inc. | 878.46M | 1.61% | 386,231 | 59.00K |
| 398 | DSGN | Design Therapeutics, Inc. | 875.52M | -4.37% | 585,952 | - |
| 399 | HSTM | HealthStream, Inc. | 864.33M | 1.55% | 53,302 | 321.12M |
| 400 | CBIO | Crescent Biopharma, Inc. | 857.73M | 3.25% | 105,291 | 11.88M |
| 401 | INMD | InMode Ltd. | 855.89M | -0.07% | 107,476 | 374.63M |
| 402 | CLYM | Climb Bio, Inc. | 851.78M | 4.07% | 377,321 | - |
| 403 | RIGL | Rigel Pharmaceuticals, Inc. | 846.38M | -4.09% | 169,720 | 276.79M |
| 404 | AVR | Anteris Technologies Global Corp. | 843.02M | 3.59% | 195,847 | 2.24M |
| 405 | CADL | Candel Therapeutics, Inc. | 832.52M | 3.18% | 431,281 | - |
| 406 | SIBN | SI-BONE, Inc. | 830.04M | 0.76% | 192,280 | 213.60M |
| 407 | ACRS | Aclaris Therapeutics, Inc. | 829.47M | 5.92% | 897,139 | 8.22M |
| 408 | SLN | Silence Therapeutics plc | 795.97M | 1.54% | 457,410 | 615.00K |
| 409 | AHCO | AdaptHealth Corp. | 795.12M | -1.65% | 1,436,097 | 3.36B |
| 410 | QDEL | QuidelOrtho Corporation | 790.67M | -2.12% | 937,318 | 2.67B |
| 411 | BBNX | Beta Bionics, Inc. | 785.52M | 5.37% | 1,197,574 | 119.01M |
| 412 | FDMT | 4D Molecular Therapeutics, Inc. | 780.05M | 7.21% | 508,962 | 92.01M |
| 413 | VREX | Varex Imaging Corporation | 779.10M | 0.14% | 194,245 | 865.00M |
| 414 | NVCT | Nuvectis Pharma, Inc. | 770.23M | -1.46% | 78,943 | - |
| 415 | PHAR | Pharming Group N.V. | 761.51M | -1.38% | 17,095 | 366.48M |
| 416 | GLAS | Glass House Brands Inc. | 757.71M | 1.39% | 330,753 | 176.98M |
| 417 | ANNX | Annexon, Inc. | 755.47M | 1.14% | 1,137,476 | - |
| 418 | COLL | Collegium Pharmaceutical, Inc. | 740.64M | - | 228,256 | 808.21M |
| 419 | GYRE | Gyre Therapeutics, Inc. | 734.81M | 2.97% | 47,028 | 109.82M |
| 420 | ACHV | Achieve Life Sciences, Inc. | 732.67M | 0.85% | 386,437 | - |
| 421 | AURA | Aura Biosciences, Inc. | 731.12M | 0.79% | 197,969 | - |
| 422 | MNPR | Monopar Therapeutics Inc. | 729.34M | -1.45% | 57,091 | - |
| 423 | MPLT | MapLight Therapeutics, Inc. | 729.15M | 0.92% | 86,986 | - |
| 424 | DBVT | DBV Technologies S.A. | 720.55M | 3.88% | 165,054 | 5.04M |
| 425 | ZVRA | Zevra Therapeutics, Inc. | 715.57M | 0.33% | 217,989 | 136.07M |
| 426 | CTMX | CytomX Therapeutics, Inc. | 710.35M | -0.91% | 1,060,581 | 18.30M |
| 427 | NGNE | Neurogene Inc. | 708.40M | -0.23% | 77,055 | 925.00K |
| 428 | PHAT | Phathom Pharmaceuticals, Inc. | 693.42M | 4.43% | 484,723 | 239.66M |
| 429 | VSTM | Verastem, Inc. | 688.28M | 3.83% | 656,228 | 87.53M |
| 430 | SGMT | Sagimet Biosciences Inc. | 685.61M | 1.38% | 194,059 | - |
| 431 | AHG | Akso Health Group | 685.23M | -4.69% | 3,583 | 13.83M |
| 432 | IRWD | Ironwood Pharmaceuticals, Inc. | 684.09M | 1.47% | 605,814 | 389.32M |
| 433 | SSII | SS Innovations International, Inc. | 678.30M | 2.27% | 66,689 | 52.40M |
| 434 | MDXG | MiMedx Group, Inc. | 674.87M | 1.31% | 288,132 | 355.17M |
| 435 | SOPH | SOPHiA GENETICS SA | 673.36M | 0.51% | 131,672 | 86.17M |
| 436 | STLN | Starling Oncology, Inc. | 659.40M | 4.86% | 444,058 | 587.24M |
| 437 | OCS | Oculis Holding AG | 657.45M | 0.85% | 53,455 | 1.45M |
| 438 | OABI | OmniAb, Inc. | 655.71M | 10.81% | 806,609 | 38.46M |
| 439 | ALT | Altimmune, Inc. | 651.63M | 2.45% | 1,211,603 | 31.00K |
| 440 | AGMB | AgomAb Therapeutics NV | 647.12M | 0.61% | 25,377 | - |
| 441 | PHR | Phreesia, Inc. | 641.19M | 0.19% | 204,788 | 507.79M |
| 442 | ANGO | AngioDynamics, Inc. | 638.17M | 1.11% | 72,077 | 320.17M |
| 443 | VALN | Valneva SE | 635.68M | -1.80% | 6,554 | 163.30M |
| 444 | BLSM | BlossomHill Therapeutics, Inc. | 632.83M | -1.00% | 110,011 | - |
| 445 | ALLO | Allogene Therapeutics, Inc. | 628.79M | 2.25% | 2,011,246 | 4.64M |
| 446 | DRUG | Bright Minds Biosciences Inc. | 628.56M | -0.20% | 14,601 | - |
| 447 | CTEV | Claritev Corporation | 623.16M | 2.20% | 73,972 | 994.67M |
| 448 | STTK | Shattuck Labs, Inc. | 620.75M | -0.24% | 305,666 | 1.00M |
| 449 | CRMD | CorMedix Inc. | 613.42M | 0.58% | 323,360 | 462.25M |
| 450 | EVO | Evotec SE | 612.30M | -2.98% | 24,653 | 819.47M |
| 451 | AQST | Aquestive Therapeutics, Inc. | 609.99M | 1.67% | 1,391,539 | 54.09M |
| 452 | ASMB | Assembly Biosciences, Inc. | 601.25M | -0.91% | 92,917 | 74.85M |
| 453 | CTKB | Cytek Biosciences, Inc. | 600.52M | 0.22% | 242,182 | 206.71M |
| 454 | TECX | Tectonic Therapeutic, Inc. | 594.50M | 4.68% | 51,457 | - |
| 455 | WEAV | Weave Communications, Inc. | 585.99M | 0.21% | 531,643 | 257.79M |
| 456 | KIDS | OrthoPediatrics Corp. | 584.08M | 1.41% | 42,713 | 252.72M |
| 457 | PRME | Prime Medicine, Inc. | 581.75M | 4.47% | 726,577 | 4.07M |
| 458 | RGNX | REGENXBIO Inc. | 575.64M | 2.23% | 368,811 | 174.48M |
| 459 | CTNM | Contineum Therapeutics, Inc. | 575.23M | 3.17% | 86,535 | - |
| 460 | TLRY | Tilray Brands, Inc. | 573.31M | 4.10% | 2,665,389 | 915.45M |
| 461 | DCTH | Delcath Systems, Inc. | 571.84M | 3.58% | 198,033 | 95.42M |
| 462 | FLGT | Fulgent Genetics, Inc. | 566.54M | 0.68% | 82,095 | 323.93M |
| 463 | SCTX | Scribe Therapeutics Inc. | 563.97M | 0.17% | 56,260 | 33.30M |
| 464 | ARVN | Arvinas, Inc. | 560.36M | 1.42% | 212,934 | 316.70M |
| 465 | EPRX | Eupraxia Pharmaceuticals Inc. | 555.37M | -2.49% | 245,588 | - |
| 466 | PROK | ProKidney Corp. | 547.20M | 0.56% | 450,277 | 818.00K |
| 467 | BWAY | BrainsWay Ltd. | 546.90M | -1.87% | 60,693 | 60.70M |
| 468 | EOLS | Evolus, Inc. | 544.26M | 5.10% | 180,832 | 316.49M |
| 469 | OVID | Ovid Therapeutics Inc. | 542.93M | 3.35% | 468,225 | 1.58M |
| 470 | CAPR | Capricor Therapeutics, Inc. | 517.44M | 6.33% | 1,599,229 | 11.13M |
| 471 | AUTL | Autolus Therapeutics plc | 515.02M | 2.93% | 847,755 | 117.39M |
| 472 | ARTV | Artiva Biotherapeutics, Inc. | 511.88M | 2.45% | 96,680 | 251.00K |
| 473 | CABA | Cabaletta Bio, Inc. | 508.64M | 9.89% | 3,486,526 | - |
| 474 | TCMD | Tactile Systems Technology, Inc. | 508.09M | 0.13% | 83,322 | 350.31M |
| 475 | IRD | Opus Genetics, Inc. | 505.41M | 0.58% | 1,331,139 | 9.86M |
| 476 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 477 | CERS | Cerus Corporation | 503.81M | 0.40% | 470,258 | 221.55M |
| 478 | ZURA | Zura Bio Limited | 503.58M | 0.86% | 321,239 | - |
| 479 | ENTX | Entera Bio Ltd. | 502.11M | 2.11% | 17,499 | 42.00K |
| 480 | EIKN | Eikon Therapeutics, Inc. | 500.48M | 3.36% | 219,494 | - |
| 481 | NRC | NRC Health | 490.83M | 5.07% | 37,567 | 140.00M |
| 482 | NPCE | NeuroPace, Inc. | 487.75M | 1.21% | 27,419 | 106.99M |
| 483 | RLMD | Relmada Therapeutics, Inc. | 484.28M | 0.44% | 469,323 | - |
| 484 | DNA | Ginkgo Bioworks Holdings, Inc. | 478.79M | 5.33% | 428,307 | 132.42M |
| 485 | PRLD | Prelude Therapeutics Incorporated | 477.90M | 1.09% | 118,297 | 22.42M |
| 486 | SPRY | ARS Pharmaceuticals, Inc. | 476.35M | 0.63% | 694,539 | 116.93M |
| 487 | SRTA | Strata Critical Medical, Inc. | 475.07M | 3.37% | 357,577 | 255.98M |
| 488 | PBYI | Puma Biotechnology, Inc. | 472.84M | 0.44% | 81,780 | 231.24M |
| 489 | SENS | Senseonics Holdings, Inc. | 472.17M | 2.53% | 139,997 | 48.55M |
| 490 | EVH | Evolent Health, Inc. | 466.94M | -1.43% | 731,446 | 2.10B |
| 491 | VOGX | Vogenx, Inc. | 465.68M | 2.29% | 29,295 | - |
| 492 | KMDA | Kamada Ltd. | 464.97M | 4.86% | 179,016 | 191.85M |
| 493 | KYTX | Kyverna Therapeutics, Inc. | 461.97M | 2.89% | 248,744 | - |
| 494 | PRTA | Prothena Corporation plc | 457.41M | -0.22% | 121,836 | 54.53M |
| 495 | SGHT | Sight Sciences, Inc. | 448.97M | 0.12% | 40,303 | 83.38M |
| 496 | RZLT | Rezolute, Inc. | 443.98M | 0.71% | 358,826 | - |
| 497 | IKT | Inhibikase Therapeutics, Inc. | 434.25M | 1.92% | 138,982 | 1.00 |
| 498 | CCCC | C4 Therapeutics, Inc. | 431.82M | - | 929,090 | 35.04M |
| 499 | EDIT | Editas Medicine, Inc. | 431.56M | 4.07% | 781,342 | 47.01M |
| 500 | ARCT | Arcturus Therapeutics Holdings Inc. | 430.33M | 2.78% | 179,548 | 29.37M |